chr3-105720058-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_170662.5(CBLB):​c.1396A>G​(p.Asn466Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,613,612 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: š‘“ 0.0016 ( 3 hom., cov: 31)
Exomes š‘“: 0.0011 ( 27 hom. )

Consequence

CBLB
NM_170662.5 missense

Scores

4
13

Clinical Significance

Benign no assertion criteria provided B:1O:1

Conservation

PhyloP100: 1.84

Publications

8 publications found
Variant links:
Genes affected
CBLB (HGNC:1542): (Cbl proto-oncogene B) This gene encodes an E3 ubiquitin-protein ligase which promotes proteosome-mediated protein degradation by transferring ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate. The encoded protein is involved in the regulation of immune response by limiting T-cell receptor, B-cell receptor, and high affinity immunoglobulin epsilon receptor activation. Studies in mouse suggest that this gene is involved in antifungal host defense and that its inhibition leads to increased fungal killing. Manipulation of this gene may be beneficial in implementing immunotherapies for a variety of conditions, including cancer, autoimmune diseases, allergies, and infections. [provided by RefSeq, Sep 2017]
CBLB Gene-Disease associations (from GenCC):
  • autoimmune disease, multisystem, infantile-onset, 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003571868).
BP6
Variant 3-105720058-T-C is Benign according to our data. Variant chr3-105720058-T-C is described in ClinVar as Benign. ClinVar VariationId is 133818.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00164 (250/152274) while in subpopulation EAS AF = 0.0453 (235/5186). AF 95% confidence interval is 0.0406. There are 3 homozygotes in GnomAd4. There are 132 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_170662.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBLB
NM_170662.5
MANE Select
c.1396A>Gp.Asn466Asp
missense
Exon 10 of 19NP_733762.2Q13191-1
CBLB
NM_001321786.1
c.1480A>Gp.Asn494Asp
missense
Exon 10 of 19NP_001308715.1
CBLB
NM_001321788.2
c.1396A>Gp.Asn466Asp
missense
Exon 10 of 19NP_001308717.1Q13191-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBLB
ENST00000394030.8
TSL:1 MANE Select
c.1396A>Gp.Asn466Asp
missense
Exon 10 of 19ENSP00000377598.4Q13191-1
CBLB
ENST00000954009.1
c.1480A>Gp.Asn494Asp
missense
Exon 11 of 20ENSP00000624068.1
CBLB
ENST00000954008.1
c.1396A>Gp.Asn466Asp
missense
Exon 10 of 20ENSP00000624067.1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
250
AN:
152156
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0452
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00405
AC:
1017
AN:
251104
AF XY:
0.00367
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0539
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00107
AC:
1559
AN:
1461338
Hom.:
27
Cov.:
32
AF XY:
0.00102
AC XY:
742
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33458
American (AMR)
AF:
0.000112
AC:
5
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0350
AC:
1389
AN:
39688
South Asian (SAS)
AF:
0.000533
AC:
46
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111558
Other (OTH)
AF:
0.00169
AC:
102
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
94
188
281
375
469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
250
AN:
152274
Hom.:
3
Cov.:
31
AF XY:
0.00177
AC XY:
132
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41558
American (AMR)
AF:
0.000196
AC:
3
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0453
AC:
235
AN:
5186
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68024
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00214
Hom.:
10
Bravo
AF:
0.00220
ExAC
AF:
0.00400
AC:
486
Asia WGS
AF:
0.0130
AC:
45
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CBLB-related disorder (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
T
Eigen
Benign
-0.16
Eigen_PC
Benign
0.019
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
0.90
L
PhyloP100
1.8
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.31
N
REVEL
Uncertain
0.32
Sift
Benign
0.043
D
Sift4G
Benign
0.66
T
Polyphen
0.061
B
Vest4
0.27
MVP
0.80
MPC
0.60
ClinPred
0.017
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.066
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61758360; hg19: chr3-105438902; COSMIC: COSV51423525; API